{"transactions":[{"id":811508,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53085,"kind":"person","name":"Shah Vinay","position":1,"cik":"0001753078","reported_name":"Shah Vinay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-09T21:00:06.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":17325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted shares of common stock that vest in full on the earlier of (i) the one-year anniversary of the grant date; or (ii) a Change of Control (as defined in the Issuer's 2017 Equity Incentive Plan, as amended), subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":17325,"source":{"system":"sec-edgar","filing":"0001213900-26-042053","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753078/000121390026042053/ownership.xml","form_type":"4"}},{"id":1127733,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53085,"kind":"person","name":"Shah Vinay","position":1,"cik":"0001753078","reported_name":"Shah Vinay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-02T20:01:34.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 29, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 29, 2025."}],"balance_after":9000,"derivative":{"exercise_price":0.688,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001213900-25-050019","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753078/000121390025050019/ownership.xml","form_type":"4"}},{"id":1361827,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53085,"kind":"person","name":"Shah Vinay","position":1,"cik":"0001753078","reported_name":"Shah Vinay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2024-11-18T21:01:06.000Z","date":"2024-11-16","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."}],"balance_after":40000,"derivative":{"exercise_price":1.06,"exercise_date":"2024-11-16","expiration_date":"2034-11-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-24-099632","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753078/000121390024099632/ownership.xml","form_type":"4"}},{"id":1665234,"issuer":{"id":84306,"kind":"organization","name":"Virpax Pharmaceuticals, Inc.","symbol":"VRPX"},"owners":[{"id":53085,"kind":"person","name":"Shah Vinay","position":1,"cik":"0001753078","reported_name":"Shah Vinay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-31T21:25:41.000Z","date":"2024-01-29","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis for 36 months commencing one year after the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis for 36 months commencing one year after the date of grant."}],"balance_after":112000,"derivative":{"exercise_price":0.3178,"expiration_date":"2034-01-28","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001213900-24-008459","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753078/000121390024008459/ownership.xml","form_type":"4"}},{"id":1805963,"issuer":{"id":84306,"kind":"organization","name":"Virpax Pharmaceuticals, Inc.","symbol":"VRPX"},"owners":[{"id":53085,"kind":"person","name":"Shah Vinay","position":1,"cik":"0001753078","reported_name":"Shah Vinay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-08-16T21:00:09.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"25% of the shares subject to the option will vest after 12 months of continuous service, and the remaining 75% of the shares subject to the Option will vest in equal monthly installments over the next 24 months of continuous service"}],"balance_after":100000,"derivative":{"exercise_price":0.99,"exercise_date":"2024-06-20","expiration_date":"2033-06-20","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-23-068265","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753078/000121390023068265/ownership.xml","form_type":"4/A","original_submission_date":"2023-06-21"}},{"id":1847915,"issuer":{"id":84306,"kind":"organization","name":"Virpax Pharmaceuticals, Inc.","symbol":"VRPX"},"owners":[{"id":53085,"kind":"person","name":"Shah Vinay","position":1,"cik":"0001753078","reported_name":"Shah Vinay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-06-21T20:18:45.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"25% of the shares subject to the option will vest after 12 months of continuous service, and the remaining 75% of the shares subject to the Option will vest in equal monthly installments over the next 36 months of continuous service"}],"balance_after":100000,"derivative":{"exercise_price":0.99,"exercise_date":"2024-06-20","expiration_date":"2033-06-20","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-23-050514","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753078/000121390023050514/ownership.xml","form_type":"4"}},{"id":2426789,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":53085,"kind":"person","name":"Shah Vinay","position":1,"cik":"0001753078","reported_name":"Shah Vinay","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2022-01-25T21:05:43.000Z","date":"2022-01-24","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis over four (4) years commencing on February 24, 2022, the one-month anniversary of the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis over four (4) years commencing on February 24, 2022, the one-month anniversary of the grant date."}],"balance_after":175000,"derivative":{"exercise_price":2.18,"exercise_date":"2022-02-24","expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001437749-22-001577","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753078/000143774922001577/rdgdoc.xml","form_type":"4"}},{"id":2651897,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":53085,"kind":"person","name":"Shah Vinay","position":1,"cik":"0001753078","reported_name":"Shah Vinay","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-29T23:36:22.000Z","date":"2021-06-29","kind":"purchase","acquired":true,"shares":1000,"price":5.31,"value":5310.0,"ownership":{"direct":true},"balance_after":190842,"source":{"system":"sec-edgar","filing":"0001437749-21-015968","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753078/000143774921015968/rdgdoc.xml","form_type":"4"}},{"id":2895578,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":53085,"kind":"person","name":"Shah Vinay","position":1,"cik":"0001753078","reported_name":"Shah Vinay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2021-01-26T21:45:39.000Z","date":"2021-01-25","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis over a four-year period commencing on February 25, 2021."}],"balance_after":60000,"derivative":{"exercise_price":5.95,"exercise_date":"2021-02-25","expiration_date":"2031-01-24","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-21-003306","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753078/000089924321003306/doc4.xml","form_type":"4"}},{"id":2955314,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":53085,"kind":"person","name":"Shah Vinay","position":1,"cik":"0001753078","reported_name":"Shah Vinay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-08T01:05:27.000Z","date":"2020-12-04","kind":"purchase","acquired":true,"shares":8000,"price":5.76,"value":46080.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $5.73 to $5.79, inclusive. The reporting person undertakes to provide Aravive, Inc., any security holder of Aravive, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 3,236 shares acquired under the Aravive, Inc. 2014 Employee Stock Purchase Plan, of which 416 shares were acquired on each of May 15, 2019, November 15, 2019 and May 15, 2020, respectively and 1,988 shares were acquired on November 13, 2020."}],"balance_after":189842,"source":{"system":"sec-edgar","filing":"0000899243-20-032920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753078/000089924320032920/doc4.xml","form_type":"4"}},{"id":3303129,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":53085,"kind":"person","name":"Shah Vinay","position":1,"cik":"0001753078","reported_name":"Shah Vinay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2020-01-24T21:13:15.000Z","date":"2020-01-22","kind":"grant","acquired":true,"shares":34826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis over four (4) years commencing on the one month anniversary of the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis over four (4) years commencing on the one month anniversary of the grant date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These options vest pro rata on a monthly basis over four (4) years commencing on the one month anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These options vest pro rata on a monthly basis over four (4) years commencing on the one month anniversary of the grant date."}],"balance_after":34826,"derivative":{"exercise_price":10.84,"exercise_date":"2020-02-22","expiration_date":"2030-01-21","underlying":"Common stock","underlying_shares":34826},"source":{"system":"sec-edgar","filing":"0000899243-20-001969","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753078/000089924320001969/doc4.xml","form_type":"4"}},{"id":3619533,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":53085,"kind":"person","name":"Shah Vinay","position":1,"cik":"0001753078","reported_name":"Shah Vinay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2019-03-04T21:54:01.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis over 48 months."}],"balance_after":38000,"derivative":{"exercise_price":5.83,"exercise_date":"2019-03-28","expiration_date":"2029-02-27","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0000899243-19-005790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753078/000089924319005790/doc4.xml","form_type":"4"}},{"id":3789935,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":53085,"kind":"person","name":"Shah Vinay","position":1,"cik":"0001753078","reported_name":"Shah Vinay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-16T22:19:08.000Z","date":"2018-10-12","kind":"grant","acquired":true,"shares":19000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On March 20, 2018, Reporting Person was granted an option to purchase 50,000 shares of the common stock of Aravive at an exercise price of $0.34 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 19,000 shares of Issuer common stock (as adjusted for the stock split) at a per share exercise price of $0.90 per share (as adjusted for the stock split). The option is fully vested with respect to all of the underlying shares and exercisable as of the effective date of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 20, 2018, Reporting Person was granted an option to purchase 50,000 shares of the common stock of Aravive at an exercise price of $0.34 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 19,000 shares of Issuer common stock (as adjusted for the stock split) at a per share exercise price of $0.90 per share (as adjusted for the stock split). The option is fully vested with respect to all of the underlying shares and exercisable as of the effective date of the merger."}],"balance_after":19000,"derivative":{"exercise_price":0.9,"expiration_date":"2028-03-20","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001209191-18-055185","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1753078/000120919118055185/doc4.xml","form_type":"4"}},{"id":3789934,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":53085,"kind":"person","name":"Shah Vinay","position":1,"cik":"0001753078","reported_name":"Shah Vinay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-16T22:19:08.000Z","date":"2018-10-12","kind":"grant","acquired":true,"shares":19000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On December 14, 2017, Reporting Person was granted an option to purchase 50,000 shares of the common stock of Aravive at an exercise price of $0.34 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 19,000 shares of Issuer common stock (as adjusted for the stock split) at a per share exercise price of $0.90 per share (as adjusted for the stock split). The option is fully vested with respect to all of the underlying shares and exercisable as of the effective date of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On December 14, 2017, Reporting Person was granted an option to purchase 50,000 shares of the common stock of Aravive at an exercise price of $0.34 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 19,000 shares of Issuer common stock (as adjusted for the stock split) at a per share exercise price of $0.90 per share (as adjusted for the stock split). The option is fully vested with respect to all of the underlying shares and exercisable as of the effective date of the merger."}],"balance_after":19000,"derivative":{"exercise_price":0.9,"expiration_date":"2027-12-14","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001209191-18-055185","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1753078/000120919118055185/doc4.xml","form_type":"4"}},{"id":3789933,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":53085,"kind":"person","name":"Shah Vinay","position":1,"cik":"0001753078","reported_name":"Shah Vinay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-16T22:19:08.000Z","date":"2018-10-12","kind":"grant","acquired":true,"shares":38001,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On June 15, 2017, Reporting Person was granted an option to purchase 100,000 shares of the common stock of Aravive at an exercise price of $0.23 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 38,001 shares of Issuer common stock (as adjusted for the stock split) at a per share exercise price of $0.66 per share (as adjusted for the stock split). The option is fully vested with respect to all of the underlying shares and exercisable as of the effective date of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 15, 2017, Reporting Person was granted an option to purchase 100,000 shares of the common stock of Aravive at an exercise price of $0.23 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 38,001 shares of Issuer common stock (as adjusted for the stock split) at a per share exercise price of $0.66 per share (as adjusted for the stock split). The option is fully vested with respect to all of the underlying shares and exercisable as of the effective date of the merger."}],"balance_after":38001,"derivative":{"exercise_price":0.66,"expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":38001},"source":{"system":"sec-edgar","filing":"0001209191-18-055185","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1753078/000120919118055185/doc4.xml","form_type":"4"}},{"id":3789932,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":53085,"kind":"person","name":"Shah Vinay","position":1,"cik":"0001753078","reported_name":"Shah Vinay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-16T22:19:08.000Z","date":"2018-10-12","kind":"grant","acquired":true,"shares":19380,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 1, 2014, Reporting Person was granted an option to purchase 51,000 shares of the common stock of Aravive at an exercise price of $0.09 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 19,380 shares of Issuer common stock (as adjusted for the stock split) at a per share exercise price of $0.24 per share (as adjusted for the stock split).  The option is fully vested with respect to all of the underlying shares and exercisable as of the effective date of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On October 1, 2014, Reporting Person was granted an option to purchase 51,000 shares of the common stock of Aravive at an exercise price of $0.09 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 19,380 shares of Issuer common stock (as adjusted for the stock split) at a per share exercise price of $0.24 per share (as adjusted for the stock split).  The option is fully vested with respect to all of the underlying shares and exercisable as of the effective date of the merger."}],"balance_after":19380,"derivative":{"exercise_price":0.24,"expiration_date":"2024-09-30","underlying":"Common Stock","underlying_shares":19380},"source":{"system":"sec-edgar","filing":"0001209191-18-055185","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1753078/000120919118055185/doc4.xml","form_type":"4"}},{"id":3789931,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":53085,"kind":"person","name":"Shah Vinay","position":1,"cik":"0001753078","reported_name":"Shah Vinay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-10-16T22:19:08.000Z","date":"2018-10-12","kind":"grant","acquired":true,"shares":178606,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of common stock of the corporation known as Aravive Biologics, Inc. (\"Aravive\") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of June 3, 2018, by and among the Issuer, Velo Merger Sub, Inc. and Aravive (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of Aravive common stock was exchanged for 2.2801 shares of the Issuer's common stock, subject to adjustment for any reverse stock split. Following the merger, the Issuer effected a reverse stock split at a ratio of one new share for every six shares of Issuer common stock outstanding and the Issuer changed its name to Aravive, Inc. All share and option numbers reflect the reverse stock split."}],"balance_after":178606,"source":{"system":"sec-edgar","filing":"0001209191-18-055185","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753078/000120919118055185/doc4.xml","form_type":"4"}}]}